Lumida
/CYH
⌘K
Community Health Systems Inc

Community Health Systems Inc

CYH
$2.92USD↑+1.04%+0.03 today

MARKET CAP

411.7M

P/E (TTM)

4.9x

FWD P/E

—

DAY RANGE

$3 – $3

52W RANGE

$2
$4

AI Summary

Stalk
TrimMedium

In a Stage 4 decline with confirmed lower highs and lower lows, CYH’s medium-term bias is bearish absent mean-reversion eligibility. The recent bounce into a cluster of falling EMAs and overhead 50/200 DMAs appears corrective. Execution should be deferred until price meets and rejects the dynamic resistance zone. A failure to reclaim that area will offer a sell entry, while a sustained break above would invalidate the bearish posture.

  • ↑Over 40 ASCs driving outpatient growth and incremental revenue
  • ↑Same-store net revenue rose 2.4% YoY from state-directed payment programs
  • ↓Net revenue fell 9.8% YoY to $2.82 B in Q2 2026 due to divestitures and uninsured patient mix
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Community Health Systems, Inc. (NYSE: CYH) is a leading healthcare provider managing a large network of general acute care hospitals across the United States. The company focuses on delivering quality healthcare services, particularly emphasizing outpatient services through strategic investments in ambulatory surgery centers (ASCs). Community Health Systems is navigating a complex healthcare landscape marked by economic pressures, regulatory changes, and shifts in patient demographics, positioning itself for growth amidst these challenges.

Bull says

  • ↑Over 40 ASCs driving outpatient growth and incremental revenue
  • ↑Same-store net revenue rose 2.4% YoY from state-directed payment programs
  • ↑Q2 free cash flow improved to $87 M from –$297 M in Q1; positive FCF targeted in 2026
  • ↑Leverage ratio improved to 6.7× by Q2 2026, showing early debt reduction progress
  • ↑Interim CEO Kevin Hammons aims to enhance operational efficiency and margins
  • ↑Strong earnings yield and positive momentum factors indicate upside potential

Bear says

  • ↓Net revenue fell 9.8% YoY to $2.82 B in Q2 2026 due to divestitures and uninsured patient mix
  • ↓Adjusted EBITDA declined to $330 M in Q2 2026 from $380 M a year ago
  • ↓Leverage remains elevated at 6.7×, heightening liquidity and refinancing risk
  • ↓Zacks cuts 2026 EPS estimate to –$1.20, signaling continued losses
  • ↓≈50% of admissions growth from uninsured patients risks volatile cash flows
  • ↓Negative growth and revision factors plus high stock volatility deter risk‐averse investors

Investment themes with CYH

Health Care Providers↓ -0.37%

UNH · CVS · HCA

Earnings Call · Q2 2025 · Mgmt. Guidance

Updated 08-15-2026bearish

Transcript signals

Bull points

  • we successfully refinanced all $700 million of our outstanding 8% senior secured notes due 2027 using proceeds from our offering of a new 10.75% senior secured notes due for 2033, and also tendered and redeemed $584 million principal value of our outstanding 2028 unsecured notes, using $438 million in cash on hand.
  • We believe there remain opportunities in this area as we stabilize and mature our new processes with our ERP.

Bear points

  • Volumes, obviously, it seems like those are coming in a little more sluggish than expected.
  • Consumer confidence consistently declined in April, May, and June to the point where we're seeing now the lowest consumer confidence probably since COVID levels.
  • final week of June beginning to see some recovery in volume back to prior levels
Read full transcript analysis ›